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Promoting Evidence-Based
Public Health Policy: CanWe
Have Better Evidence AndMore
Action?
When the science base is adequate, policymakers can more rapidly
translate results into decisions and then into actions.
by Jonathan E. Fielding and Peter A. Briss
ABSTRACT: Evidence-based approaches (those explicitly linked to the best available scien-
tific evidence and reflecting community preferences and feasibility) are increasingly used to
inform health policy decision making on the burden of a disease attributable to particular
causes, interventions and policies that might work to confront those causes, and issues of
community fit and feasibility. This paper introduces several tools for evidence-based public
health: the health impact assessment, the systematic review, and a portfolio for assuring
community fit and feasibility. Discussion of these tools serves as a springboard to consider
how to better bring scientific evidence to bear on real-life health issues. [Health Affairs 25,
no. 4 (2006): 969–978; 10.1377/hlthaff.25.4.969]
M
any improvements in the health of populat ions result from
the introduction of evidence-informed policies or programs that affect
the likelihood of acquiring a disease, the severity of the disease, the re-
ceipt of timely and effective care and treatment, and, for communicable diseases,
the likelihood of disease transmission. Harnessing and constantly improving the
available science in support of effective public health action reflects a centuries-
long public health tradition. Examples include a very broad range of activities
such as the introduction of childhood vaccination, environmental changes that im-
prove workplace safety, fluoridation of community water supplies, and improved
public health interventions to control the risk factors for heart disease and stroke.1
These and other successes in using the best available science to support com-
munity health are only part of the picture. Despite the billions of U.S. tax dollars
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spent on research and the more than a trillion spent on service delivery, movement
of evidence-based interventions into communities and health systems is often
slow.2 Making faster and better use of scientific information could increase the
value of public investment and help ensure that policies designed to improve
health have their desired effects. Accelerating the integration of scientific discov-
eries into routine public health practice and policy deserves priority attention.
 Key questions for policymakers. Public and private decisionmakers on
health issues must address a series of difficult questions when choosing programs
and policies: What is the likely disease burden that might be prevented or reduced?
Which programs and policy options are likely to result in meaningful improvements
in health? How will the benefits be distributed among the affected groups? Which
potential solutions are appropriate and feasible for a specific situation, considering
(1) the fit between strategy and the community context, (2) political and technical
feasibility, and (3) cost and cost-effectiveness?
Public health science has the potential to inform these decisions but requires
effort and investment at every stage, from production of primary studies to syn-
thesis of results across studies and then to translation of research-tested findings
into effective community action. For the health of the public to be protected and
improved, it is critical that interventions be based on the best possible scientific
evidence; that we continuously strive to improve and expand the scientific evi-
dence base; and that we actively promote the use of the best-available, science-
tested programs and policies.
 Working definition. For this paper we have adopted Neal Kohatsu’s definition
of evidence-based public health: the process of integrating science-based interventions
with community preferences to improve the health of populations.3 Lucy Rychetnik
and colleagues, expanding on earlier work by Ross Brownson and colleagues, have
identified three types of scientific evidence that can support evidence-based public
health decisions.4 Type 1 evidence defines causes of disease and their magnitude, se-
verity, and preventability and helps determine that “something should be done.”
Type 2 evidence shows that specific interventions do or do not work to promote
health and help inform decisions about “which interventions or policies should be
done.” Type 3 evidence shows how and under what conditions interventions were
implemented and how they were received, informing decisions about “how some-
thing should be done.”
All of these types of evidence can come from a range of sources with differing
levels of rigor and local relevance. A person’s hunch, an anecdotal observation, the
expert opinion of a group, a formally designed and executed scientific study, or a
group of studies all can constitute evidence. In general, however, scientific studies
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“Making faster and better use of scientific information could
increase the value of public investment.”
produce more reliable information than the alternatives, and multiple studies are
better than single ones.
 Key questions for evaluating evidence. To improve their confidence in the
reliability of the evidence for supporting policy choices, policymakers might ask the
following questions: Were those who participated in producing or evaluating the
scientific information well qualified? Was the process for considering the evidence
transparent and free of conflicts of interest? What kind of evidence was considered?
Was it from scientific studies or from anecdote or expert opinion? Was the informa-
tion confirmed in more than one study? Do the studies represent all of the available
studies on the topic? Were they of good quality? How were the results summarized?
How do the conclusions relate to the information presented?
 Tools to support evidence-based public health. Evidence-based public
health provides a range of sophisticated tools for marshalling the best available sci-
entific information to support public health decisions. The tools discussed in this
paper—health impact assessment (HIA), systematic reviews, and a portfolio of tools
for assuring community fit and feasibility—are essential supports to evidence-based
public health. Our intent is to illustrate the challenges and opportunities inherent in
using scientific evidence to help address real-life health challenges and provide
some examples of how these tools have contributed to real-world decisions.
HIA: To Determine Whether Something Should Be Done
Decision making about health-related programs and policies first require credi-
ble information on causes of health burden and health disparities. Social, eco-
nomic, and physical environments are the major underlying determinants of the
health of populations and variations among subpopulations. For example, eco-
nomic disparities, lack of educational opportunities, and lack of affordable hous-
ing all contribute to preventable disease and injury burden.5 Thus, understanding
the contributions of these factors to the rates and severity of many diseases is criti-
cal to health improvement strategies.
 Assessing the health burden and improvement potential. The HIA is one
approach to assessing both the health burden from conditions in sectors other than
health and the potential of health improvements by modifying those conditions. An
HIA is a combination of procedures, methods, and tools by which a policy, program,
or project may be judged as to its potential effects on the health of a population and
the distribution of those effects within the population.6 HIA can facilitate inter-
sectoral action to improve health by evaluating health effects of actions in sectors
such as agriculture, education, economic policy, transportation, and housing.
HIA, more commonly employed in Western Europe and New Zealand and Aus-
tralia than in the United States, can be used at the community level to maximize
positive health effects and minimize adverse health effects of a project—such as an
airport enlargement, a new housing development, or a transit system expansion. It
can also be used at a policy level to determine the potential health effects, both
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positive and negative, of a specific proposal for an ordinance, law, or regulation.
In its broader context, HIA can be used both to influence specific proposals and
to help decisionmakers learn about the importance of considering health effects in
many decisions in nonhealth sectors. For example, studies in San Francisco and
Los Angeles have assessed the likely health effects of requiring city contractors to
pay a “living wage” to their employees and provide or contribute a fixed amount
toward their health insurance coverage.7 Benefits to health included those result-
ing from higher overall income as well as those associated with obtaining cover-
age. Another recent study estimated the health effects of establishing a walk- or
bike-to-school program at elementary schools.8
 Requirements for HIA use. HIA requires a high degree of interdisciplinary
and intersectoral collaboration, well-trained practitioners, appropriate data sets for
analysis, and funders that recognize the value of the collaborations and the informa-
tion. Most public health researchers are not familiar with the transportation litera-
ture or the literature on educational interventions to improve academic perfor-
mance. Identifying and combining results from studies of acceptable quality and
execution in sectors other than health may require different search strategies and
criteria for which studies should be included. In addition, the health effects of spe-
cific policies need to be systematically identified and quantified. As an example,
positive effects of increased walking to school include more physical activity for
children and their parents and a possible small reduction in obesity. Adverse effects
of walking to school might include an increased risk of an injury either through be-
ing hit by a car or bike or from interpersonal violence. Again, community context is
important. In some parts of urban areas, the level of violence makes a walkability
program for children inadvisable.9
 Impact outside the health sphere. Because of their focus on specific policy
options facing decisionmakers, HIA is more likely than other evidence-based
decision tools to affect decisions outside the health sector. HIA educates decision-
makers about how the public’s health is strongly influenced by many decisions in
spheres outside health. In so doing, HIA can expand the involvement of public
health agencies into new forums. In Los Angeles, for example, the health department
is increasingly involved in policy discussions about land use, development of pre-
schools, and affordable housing.
However, the HIA literature is in an early stage of development.10 Defining and
quantifying how the public’s health is affected by altering policies in other sectors
remains unexplored or elusive in many cases. For example, what might be the ben-
efits to health over the life course of reducing the high school dropout rate by a
certain percentage? To what extent could health be improved and disparities re-
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“HIA can help decisionmakers learn about the importance of
considering health effects in many decisions in nonhealth sectors.”
duced by a sustained reduction of one-third in the number of families living below
the federal poverty level?
There is no registry of HIAs where public health and other decisionmakers can
find out whether specific questions have been addressed and the answers ob-
tained. However, as the importance of the underlying determinants on health be-
comes more widely appreciated, it is likely that there will be increased demand for
HIAs and access to this body of analytic studies. As legislators at the national,
state, and local levels recognize that important health effects, both positive and
negative, can ensue from policy decisions in other sectors such as education, wel-
fare, transportation, urban planning, commerce, and agriculture, they could re-
quire the performance of HIAs before major legislative proposals are considered.
Systematic Reviews: To Assess What Should Be Done
A systematic review is a formal process that identifies all of the relevant scien-
tific studies on a topic; assesses their quality, individually and collectively; and
sums up their results. Systematic approaches for summarizing scientific evidence
and linking that evidence to practice and policy recommendations increase the
transparency, understandability, and credibility of recommendations.
Systematic reviews make it easier for practitioners and policymakers to under-
stand all of the relevant information that is available, how it was collected and as-
sembled, and how the conclusions and recommendations relate to the information
that was reviewed. For example, the Cochrane Collaboration was created in 1993
to facilitate well-informed decisions about health care issues by preparing, main-
taining, and promoting the accessibility of systematic reviews of the effects of
health care interventions. By 1999 Cochrane had expanded to address issues of
health promotion and public health.11 The Campbell Collaboration, founded in
2000, has aims that are similar to those of Cochrane for topics related to educa-
tion, crime, justice, and social welfare.12 The Campbell Collaboration reflects
growing interest in systematic reviews within the social science community.
In the health sphere, reviews now summarize information on the efficacy of
medical treatments, clinical preventive services, public health interventions and
policies, and related social policies. Although most published systematic reviews
have focused on clinical issues, there is nothing inherent in systematic reviews or
evidence-based practice that limits them to either clinical issues or specific re-
search designs such as randomized trials.13 There is increasing international inter-
est in broadening the range of topics and types of evidence that are considered.
Use of scientific evidence to support practice recommendations has been most
prominent in clinical medicine. Early examples of the use of systematic reviews to
support recommendations about clinical preventive services came from the Cana-
dian Task Force on the Periodic Health Examination and the U.S. Preventive Ser-
vices Task Force.14 More recently, the desire to bring the best available science to
bear in improving health at the population level resulted in the creation of the
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Task Force on Community Preventive Services to support public health decision
making.15
The following examples of systematic reviews and evidence-based recommen-
dations, from the task force’s Guide to Community Preventive Services and selected
other sources, illustrate the types of conclusions reached and how results have or
have not been translated into practice, policy, and additional research.
 Contribution to tobacco control policy. Tobacco use remains the single larg-
est cause of preventable premature death in the United States, and systematic re-
views have identified many effective counseling and drug therapies.16 Although most
smokers want to quit completely, fewer than 30 percent receive counseling, and nic-
otine replacement therapy is prescribed for fewer than 5 percent.17 A systematic re-
view of published studies, conducted on behalf of the Task Force on Community
Preventive Services, has also shown that providing effective cessation therapies at
low or no cost results in greater use of these effective therapies and more success in
quitting.18 For example, these reviews have shown that for every 100 smokers cov-
ered by these policies, about 8 additional people stop smoking. Based on this review,
the task force recommended that this strategy be implemented on the basis of suffi-
cient evidence of effectiveness.
Availability of better scientific consensus on the efficacy of smoking cessation
treatment and on the contributions payment policies make to increased cessation
might have contributed to the increased use of these policies. For example, from
the mid-1990s to the mid-2000s, the numbers of state Medicaid programs cover-
ing these treatments has increased from twenty-four to forty, and coverage has
also been added by Medicare and the Department of Veterans Affairs.19
 Contribution to reducing alcohol-related motor vehicle crashes. Alcohol-
related motor vehicle crashes resulted in more than 16,000 deaths and 300,000 inju-
ries in the United States in 2000. Lowering legal blood alcohol concentration (BAC)
for drivers has been proposed as a policy response that might reduce this burden of
injury and death. In 2001 a systematic review showed that laws allowing drivers a
BAC of 0.08 percent versus 0.1 percent results in a median decrease in fatal alcohol-
related motor vehicle crashes of about 7 percent. Based on this review, the task force
recommended that this policy be implemented on the basis of sufficient evidence of
effectiveness.20
This recommendation was influential in Congress’s decision to include incen-
tives (in the form of federal highway construction funds) for states to pass such
laws. At the time of the congressional incentives, seventeen states had 0.08 per-
cent BAC laws. By the end of 2004, all fifty states, the District of Columbia, and
Puerto Rico had enacted 0.08 percent BAC laws.21 Although most states had mul-
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“Availability of better scientific consensus on the efficacy of smoking
cessation treatment might have contributed to its increased use.”
tiple laws aimed at reducing alcohol-impaired driving, addition of 0.08 laws in the
thirty-three states that did not previously have them should save at least 400–600
lives each year and prevent a much larger number of disabling injuries.22
 Contribution to use of early childhood education programs. Child devel-
opment is a powerful determinant of health in adult life, as indicated by the strong
relationship in adulthood between level of education and health status. Low socio-
economic status in early life puts children’s cognitive and behavioral development at
risk. Comprehensive preschool programs for low-income children ages 3–5, can im-
prove readiness for school. A systematic review of published studies, conducted on
behalf of the Task Force on Community Preventive Services, found that publicly
funded comprehensive early childhood education programs are effective in improv-
ing preparedness to learn: Children who participated in these programs are 13 per-
cent less likely to be “held back” in grade level and 14 percent less likely to be placed
in special education programs in the future.23 Based on strong evidence from this re-
view, the task force issued a recommendation that this intervention be imple-
mented. Policymakers have used this information to support their funding deci-
sions. For example, in 2005 the California and Los Angeles First 5 Commissions,
which receive tobacco tax revenue funds to improve health and development of chil-
dren ages 0–5, used this type of evidence in part to support their decision to invest
more than $100 million per year in new preschool classes.24
 Counterexample: continued use of ineffective drug abuse programs. Al-
though systematic reviews and evidence-based recommendations are being used to
encourage new interventions or expand use of those already in place, the news is less
optimistic about use of reviews to encourage decisionmakers to substitute more-
effective choices for the less-effective ones that are already in widespread practice.
This reflects multiple technical and human challenges: (1) Studies that do not show
effectiveness are less likely than those showing effectiveness to be published; (2)
proving no effect is inherently difficult, and it is often difficult to rule out the possi-
bility that an intervention could have some effect; and (3) people are often resistant
to new information that challenges their preconceptions or interests.
Substance use (including tobacco, alcohol, and illegal drugs) often starts in ad-
olescence and results in serious health consequences. There is widespread social
consensus that something should be done, and school-based programs have the
potential to reach most adolescents. One particular program, D.A.R.E. (Drug
Abuse Resistance Education), is widely used in U.S. schools and costs about three-
quarters of a billion dollars annually.25 However, available good-quality studies
and reviews generally show that this program has no or negligible effects on drug
use behavior.26 Given this program’s continuing widespread use, reviews have not
had a substantial impact on discouraging its use and encouraging substitution of
more-effective choices.
 Contributions to additional needed research. An underappreciated benefit
of reviews is in helping to assure that new research takes full account of current ar-
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eas where we do not yet know enough. Some countries, including the United King-
dom and Denmark, have begun requiring references to systematic reviews before
funding new research.27 In the United States, such requirements do not exist, but
the Guide to Community Preventive Services is beginning to influence new research: For
example, the CDC and the National Institutes of Health (NIH) have together com-
mitted $2.5 million annually to a Cancer Prevention and Control Research Network
that provides an infrastructure for filling important gaps in research, many of which
were identified in community-guide systematic reviews.28
Portfolio Of Tools: For Improving Community Fit And
Feasibility
The science base for assuring that an intervention or policy will be appropriate
and feasible in particular settings and populations is less developed than the sci-
ence base for assessing whether something should be done or whether something
works generally. However, a range of techniques and tools are evolving in this area.
Some of the important ones include the following. (1) Participatory research: per-
forming research in collaboration with those affected by the issue under study for
the purpose of taking action or making change has the potential to increase the
relevance of research findings and their subsequent use in communities.29 (2) In-
creasing collection and reporting of qualitative information about the context in
which research studies were conducted will provide users with more information
about whether particular strategies are likely to be feasible and useful in local con-
texts as well as providing a basis for allowing systematic reviews to assess the im-
pact of context on results.30 (3) Economic evaluations of public health interven-
tions will provide critical information about costs and value. (4) Finally, decision
analytic and other modeling approaches can be very helpful in systematically col-
lecting and analyzing available data, comparing the value of two or more decision
options, and assessing the importance of uncertainties on results.31
Concluding Remarks
Much more can be done to assure that original public health studies and syn-
theses are available and considered when decisions are needed across a full range
of population-oriented interventions. Policymakers can help by assuring adequate
funding for both studies and syntheses that fill high-priority gaps in knowledge.
They can also promote interactions between themselves and researchers to in-
crease the relevance of the research enterprise to critical policy questions.
When the science base is adequate to support decisions, more can be done to
rapidly translate results into decisions on expanding or changing programs and
policies designed to improve health. Dissemination of results can be accelerated,
tools developed to facilitate their use in a variety of settings, incentives provided
for implementing recommended programs and policies based on the best evi-
dence, and results measured.
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No evidence-based tool will or should ever constitute the sole base on which a
decision rests. High-quality, evidence-based information is not always available,
and even when it is, policy choices should always be informed by available re-
sources, community priorities, perceived value, feasibility, culture, and other fac-
tors.32 Evidence-based information will not change strong ideologic support for or
opposition to policy positions. However, the best available evidence can contrib-
ute to carefully vetted, balanced information that can help the open-minded to
make better-informed choices.
The findings and conclusions in this report are those of the authors and do not necessarily represent the views of the
Centers for Disease Control and Prevention.
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